Search results
Results From The WOW.Com Content Network
Anthracimycin is a polyketide antibiotic discovered in 2013. Anthracimycin is derived from marine actinobacteria . In preliminary laboratory research, it has shown activity against Bacillus anthracis , [ 1 ] the bacteria that causes anthrax , and against methicillin-resistant Staphylococcus aureus (MRSA).
If infection occurs, treatment is with antibiotics and possibly antitoxin. [6] The type and number of antibiotics used depend on the type of infection. [5] Antitoxin is recommended for those with widespread infection. [5] A rare disease, human anthrax is most common in Africa and central and southern Asia. [11]
Levofloxacin is used to treat infections including: respiratory tract infections, cellulitis, urinary tract infections, prostatitis, anthrax, endocarditis, meningitis, pelvic inflammatory disease, traveler's diarrhea, tuberculosis, and plague [7] [3] and is available by mouth, intravenously, [7] and in eye drop form.
For premium support please call: 800-290-4726 more ways to reach us
Raxibacumab [2] is a human monoclonal antibody intended for the prophylaxis and treatment of inhaled anthrax.Its efficacy has been proven in rabbits and monkeys. [3] In December 2012 raxibacumab was approved in the United States for the treatment of inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs, and for prophylaxis of inhalational anthrax ...
Anthrax immune globulin, tradename Anthrasil, is a human immune globulin that is used in combination with antibiotics to treat anthrax. [2] It was developed by Cangene and purchased in 2011 by the Biomedical Advanced Research and Development Authority (BARDA) under Project Bioshield .
Cethromycin, trade name Restanza (initially known as ABT-773 [1] [2]) is a ketolide antibiotic undergoing research for the treatment of community acquired pneumonia (CAP) [1] [3] [4] [5] and for the prevention of post-exposure inhalational anthrax, and was given an "orphan drug" status for this indication. [6]
Symptoms in humans usually begin between one day to one week after exposure, but it may take as many as 60 days for them to present in humans. Symptoms depend on how anthrax enters the body.